Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

PHASE3CompletedINTERVENTIONAL
Enrollment

870

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions
Onychomycosis
Interventions
DRUG

IDP-108

Topical application once a day for 48 weeks

DRUG

Vehicle

Topical application once a day for 48 weeks

Trial Locations (72)

11040

Impact Clinical Trials, New Hyde Park

17033

Penn State Milton S. Hershey Medical Center, Hershey

19107

Temple University School of Podiatric Medicine, Philadelphia

23507

Virginia Clinical Research, Inc, Norfolk

24501

The Education and Research Foundation, Inc., Lynchburg

29607

Palmetto Clinical Trial Services, LLC, Greenville

30078

Gwinnett Clinical Research Center, Inc., Snellville

30909

Augusta Centre for Dermatology and Skin Renewal, LLC, Augusta

32174

Ameriderm Research, Ormond Beach

32701

Foot and Ankle Associates of Florida, Inc, Altamonte Springs

33144

International Dermatology Research, Inc., Miami

35233

University of Alabama, Birmingham, Birmingham

37072

Rivergate Dermatology, Goodlettsville

40202

Dermatology Specialists, Louisville

44118

Haber Dermatology & Cosmetic Surgery, South Euclid

45249

Radiant Research, Cinncinati

47714

Hudson Dermatology, Evansville

48038

Michigan Center for Research Corp., Clinton Township

53209

Aurora Advanced Healthcare, Inc. - Clinical Research Center, Milwaukee

75246

Baylor Research Institute, Dallas

77845

J & S Studies, Inc., College Station

78229

Stephen Miller, MD, PA, San Antonio

78705

Austin Dermatology Associates, Austin

80501

Longmont Medical Research Network, Longmont

83704

Northwest Clinical Trials, Boise

84124

Dermatology Resarch Center, Salt Lake City

85050

HOPE Research Institute, Phoenix

87106

Academic Dermatology, Albuquerque

92123

Therapeutics Clinical Research, San Diego

University Clinical Trials, Inc, San Diego

94115

University of California, San Francisco, San Francisco

97219

Oregon Dermatology and Research Center, Portland

06511

The Savin Center, PC, New Haven

T2S 3B3

Kirk Barber Research, Calgary

T5K 1X3

Stratica Medical, Edmonton

L4M 6L2

Ultranova Skincare, Barrie

N5X 2P1

Mediprobe Research, New London

P1B 3Z7

North Bay Dermatology Centre, North Bay

N8W 1E6

XLR8 Medical Research, Windsor

G1V 4X7

Centre de Recherche Dermatologique du Québec Métropolitain, Québec

Unknown

Kaken Investigational Site, Dazaifu

Kaken Investigational Site - Chuo-ku #1, Fukuoka

Kaken Investigational Site - Chuo-ku #2, Fukuoka

Kaken Investigational Site - Higashi-ku, Fukuoka

Kaken Investigational Site - Minami-ku #1, Fukuoka

Kaken Investigational Site - Minami-ku #2, Fukuoka

Kaken Investigational Site, Itoshima

Kaken Investigational Site - Atsubetsu-ku #1, Sapporo

Kaken Investigational Site - Atsubetsu-ku #2, Sapporo

Kaken Investigational Site - Atsubetsu-ku #3, Sapporo

Kaken Investigational Site - Chuo-ku, Sapporo

Kaken Investigational Site - Kita-ku, Sapporo

Kaken Investigational Site - Kiyota-ku, Sapporo

Kaken Investigational Site - Nishi-ku, Sapporo

Kaken Investigational Site - Shiroishi-ku, Sapporo

Kaken Investigational Site - Teine-ku #1, Sapporo

Kaken Investigational Site - Teine-ku #2, Sapporo

Kaken Investigational Site, Kawasaki

Kaken Investigational Site, Nagasaki

Kaken Investigational Site, Ginowan

Kaken Investigational Site, Naha

Kaken Investigational Site, Nakagami

Kaken Investigational Site - Okinawa #1, Okinawa

Kaken Investigational Site - Okinawa #2, Okinawa

Kaken Investigational Site, Urasoe

Kaken Investigational Site, Kawaguchi

Kaken Investigational Site - Nakano-ku #1, Nakano-ku

Kaken Investigational Site - Nakano-ku #2, Nakano-ku

Kaken Investigational Site - Setagaya-ku #1, Setagaya-ku

Kaken Investigational Site - Setagaya-ku #2, Setagaya-ku

Kaken Investigational Site - Shinagawa-ku #1, Shinagawa-ku

Kaken Investigational Site - Shinagawa-ku #2, Shinagawa-ku

Sponsors
All Listed Sponsors
lead

Dow Pharmaceutical Sciences

INDUSTRY